23例手部腱鞘巨细胞瘤患者术后功能恢复及复发随访结果分析

doi:10.13481/j.1671-587x.20200526

Abstract

Abstract: Objective: To explore the preoperative diagnosis, surgical treatment, functional exercise and recurrence factors of tenosynovial giant cell tumor (TGCT) in hand,and to provide the theoretical basis for the diagnosis and treatment of TGCT in hand. Methods: The clinical materials of 23 patients with TGCT in hand were retrospectively analyzed.The preoperative ultrasound diagnosis and postoperative pathology diagnosis of the patients were compared. The X-ray examination results of hands were analyzed. The superficial local ultrasound examination of the patients was followed-up. The patients were asked to fill in the Michigan Hand Outcomes Questionnaire (MHQ), and E-Link was used to measure the grip strength of the affected side and the healthy side of the patients three times, the total active motion(TAM) values of both sides were calculated, and the subjective satisfaction and hand function of the patients were evaluated. Results: There were 23 patients with TGCT in hand, including 4 males and 19 females, aged 18-68 years old, mean (48.5±15.1) years old;among them, 12 cases of left-handed, 11 cases of right-handed; 21 cases of local nodular type TGCT(L-TGCT) and 2 cases of diffuse type TGCT(D-TGCT). The preoperative ultrasound diagnosis result was in accord with the postoperative pathology diagnosis results.There was no bone damage in X-ray examination before operation. The patients were followed up for 6-26 months,mean (16±6.5) months;the results of superficial local ultrasound showed recurrence in 1 case,and the recurrence rate was 4.3%. The grip strength and TAM values of the affected sides in 2 patients with D-TGCT were significantly lower than those of the healthy side; the grip strength and TAM values of 21 patients with L-TGCT had no significant differences compared with the healthy sides.The MHQ scores were less than 80 in 3 cases and more than 80 in 20 cases. Conclusion: Complete resection of TGCT can reduce the recurrence rate, and active functional exercise can achieve good rehabilitation effect.

Key words: tenosynovial giant cell tumor, superficial local ultrasound, grip strength, total active motion, recurrence

CLC Number:

R686.1

ZHANG Yiqun, JIANG Weibo, YUAN Sheng, YU Wei. Analysis on follow-up results of postoperative function and recurrence of 23 patients with tenosynovial giant cell tumor in hand[J].Journal of Jilin University(Medicine Edition), 2020, 46(05): 1061-1064.

References

[1] 王澍寰,田光磊. 手外科学[M].3版.北京:人民卫生出版社,2011:736.
[2] SANSONE V, LONGHINO V. What's in a name? A call for consistency in the classification of tenosynovial giant cell tumour[J].Knee, 2018,25(6):1322-1323.
[3] GOUIN F, NOAILLES T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)[J]. Orthop Traumatol Surg Res, 2017, 103(1S):S91-S97.
[4] GE Y X,GUO G,YOU Y Q,et al. Magnetic resonance imaging features of fibromas and giant cell tumors of the tendon sheath:differential diagnosis[J]. Eur Radiol,2019,29(7):3441-3449.
[5] 顾玉东,王澍寰,侍德. 手外科手术学[M].2版. 上海:复旦大学出版社,2010:1053-1054.
[6] KOUTSERIMPAS C, KASTANIS G, IOANNIDIS A, et al. Giant cell tumors of the tendon sheath of the hand:an 11-year retrospective study[J]. J BUON:Off J Balkan Union Oncol, 2018, 23(5):1546.
[7] GUPTA K, DEY P, GOLDSMITH R, et al. Comparison of cytologic features of giant-cell tumor and giant-cell tumor of tendon sheath[J]. Diagn Cytopathol, 2010, 30(1):14-18.
[8] ÇEVIK H B, KAYAHAN S, ECEVIZ E, et al. Tenosynovial giant cell tumor in the hand:experience with 173 cases[J]. J Hand Surg Asian Pac Vol, 2020, 25(2):158-163.
[9] RAVI V, WANG W L, LEWIS V O. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis[J]. Curr Opin Oncol, 2011,23(4):361-366.
[10] 计学, 马吉军, 李超. 腕部切割伤继发腱鞘巨细胞瘤一例[J]. 中华手外科杂志, 2011,27(5):262-262.
[11] MONDAL K, MANDAL R, KHAN K, et al. Pitfalls in the cytological diagnosis of tenosynovial giant cell tumor:An illustration of eight discordant cases[J]. Diag Cytopathol, 2018,46(3):250-257.
[12] LYNSKEY S J, PIANTA M J. MRI and thallium features of pigmented villonodular synovitis and giant cell tumours of tendon sheaths:A retrospective single centre study of imaging and literature review[J]. Br J Radiol, 2015, 88(1056):20150528.
[13] MASTBOOM M J L, VERSPOOR F G M, HANFF D F, et al. Severity classification of tenosynovial giant cell tumours on MR imaging[J]. Surg Oncol, 2018, 27(3):544-550.
[14] AGARWAL A, PRAKASH M, GUPTA P, et al. Soft tissue masses of hand:a radio-pathological correlation[J]. Radiol Res Pract, 2015, 2015:752054.
[15] MONAGHAN H, SALTER D M, AL-NAFUSSI A. Giant cell tumour of tendon sheath (localised nodular tenosynovitis):clinicopathological features of 71 cases[J]. J Clin Pathol, 2001, 54(5):404-407.
[16] GIUSTINI N, BERNTHAL N M, BUKATA S V, et al. Tenosynovial giant cell tumor:case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature[J]. Clin Sarcoma Res, 2018, 8:14.
[17] BRAHMI M, VINCENEUX A, CASSIER P A. Current systemic treatment options for tenosynovial giant cell tumor/pigmented villonodular synovitis:targeting the CSF₁/CSF1R axis[J]. Curr Treat Options Oncol, 2016, 17(2):10.
[18] OZBEN H, COSKUN T. Giant cell tumor of tendon sheath in the hand:analysis of risk factors for recurrence in 50 cases[J]. BMC Musculoskelet Disord, 2019, 20(1):457.
[19] WOLFE S W,HOTCHKISS R N,PEDERSON W C,等. 田光磊,蒋协远,陈山林,等译. 格林手外科手术学[M]. 北京:人民军医出版社,2012:2008-2009.
[20] 潘勇卫, 田光磊, 荣国威,等. 手部伴骨破坏的腱鞘巨细胞瘤[J]. 中华手外科杂志, 2004, 20(3):152-154.
[21] ADAMS E L, YODER E M, KASDAN M L. Giant cell tumor of the tendon sheath:experience with 65 cases[J]. Eplasty, 2012, 12:e50.

Analysis on follow-up results of postoperative function and recurrence of 23 patients with tenosynovial giant cell tumor in hand

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 6

Metrics

Comments

Recommended 0

[1]	DUAN Jiqing, SUO Jian, SUN Donghui. Application of two-step procedure to turn rectum out from abdominal cavity in radical resection of low rectal carcinoma by natural orifice specimen extraction surgery: A report of 39 cases [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 683-687.
[2]	WANG XI, HAN Jinhua, LI Yunfeng, YANG Yanming. Observation on short-term efficacy of thermal-therapy combined with ¹²⁵I particles in treatment of recurrent rectal cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 963-966.
[3]	ZHANG Mao,SU Qing-xiu,YANG Jin-lei,JIN Hai-guo,DONG Ying,WU Dan，WANG Fu-xiang. Comparison of dosimetric parameters of re-irradiation in patients with locally recurrent nasopharyngeal carcinoma [J]. Journal of Jilin University Medicine Edition, 2014, 40(05): 1085-1089.
[4]	LI En-xi，YIN Wei-min，WANG Xu，MA Ke-wei. Efficacy and influencing factor analysis of GP regimen in postoperative adjuvant chemotherapy for non-small-cell lung cancer  [J]. Journal of Jilin University Medicine Edition, 2013, 39(1): 122-127.
[5]	LI Dan-dan,ZHAO Jie,SUN Hui,WEN Qiang,GAO Shi,MA Qing-jie,ZHAO Guo-qing. Relationship between HIF-lα expression and recurrence of differentiated thyroid carcinoma after complete thyroidectomy combined with ¹³¹I treatment [J]. J4, 2008, 34(5): 867-870.
[6]	WANG Bin,SONG Yan. Expression of osteopontin in colon cancer tissue and detection of osteopontin in serum [J]. J4, 2007, 33(2): 324-326.